Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.1M Sell
12,167
-118
-1% -$162K 0.2% 106
2025
Q4
$13.1M Sell
12,285
-1,101
-8% -$1.15M 0.19% 114
2025
Q3
$13M Sell
13,386
-731
-5% -$575K 0.16% 133
2025
Q2
$11.3M Sell
14,117
-381
-3% -$273K 0.15% 151
2025
Q1
$9.61M Buy
14,498
+8,362
+136% +$6.08M 0.15% 160
2024
Q4
$4.25M Buy
6,136
+1,856
+43% +$1.33M 0.06% 326
2024
Q3
$3.57M Buy
4,280
+407
+11% +$364K 0.05% 364
2024
Q2
$3.96M Buy
3,873
+182
+5% +$175K 0.06% 321
2024
Q1
$3.58M Buy
3,691
+183
+5% +$162K 0.06% 346
2023
Q4
$2.66M Buy
3,508
+291
+9% +$192K 0.05% 423
2023
Q3
$1.89M Sell
3,217
-62
-2% -$41.2K 0.04% 483
2023
Q2
$2.38M Buy
3,279
+680
+26% +$462K 0.05% 429
2023
Q1
$1.77M Sell
2,599
-40
-2% -$25.7K 0.04% 482
2022
Q4
$1.44M Sell
2,639
-178
-6% -$93.2K 0.03% 533
2022
Q3
$1.17M Buy
2,817
+249
+10% +$125K 0.03% 611
2022
Q2
$1.22M Sell
2,568
-479
-16% -$267K 0.03% 619
2022
Q1
$2.04M Buy
3,047
+407
+15% +$273K 0.04% 497
2021
Q4
$2.1M Buy
2,640
+290
+12% +$230K 0.04% 499
2021
Q3
$1.75M Buy
2,350
+667
+40% +$524K 0.03% 554
2021
Q2
$1.16M Buy
1,683
+522
+45% +$344K 0.02% 690
2021
Q1
$717K Buy
+1,161
New +$644K 0.01% 823

Other funds holding ASML

Oppenheimer & Co's ASML Position: Q1 2026 in Review

Oppenheimer & Co reduced its ASML (ASML) stake by 0.96% in Q1 2026, selling an estimated $162K and leaving 12,167 shares worth $16.1M. The position accounts for 0.2% of the portfolio, ranked #106.

Oppenheimer & Co first reported a position in ASML in Q1 2021 and has held it in 21 quarters since. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

  • Oppenheimer & Co held 12,167 shares of ASML worth $16.1M as of Q1 2026.
  • Oppenheimer & Co sold 118 ASML shares in Q1 2026, an estimated $162K.
  • ASML made up 0.2% of Oppenheimer & Co's portfolio in Q1 2026, its #106 holding.
  • Oppenheimer & Co first reported a position in ASML in Q1 2021 and has held it in 21 quarters since.
  • 2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.